glp-1 crohn's disease ADJUNCTIVE RECEPTOR AGONISTS IN DISEASE: REDUCED STEROID DEPENDENCE AND HOSPITALIZATIONS IN A REAL-WORLD MULTI-NETWORK COHORT GLP-1 IBD obesity "inflammatory bowel
Description
Keep a detailed record of your symptoms, including when they started, their frequency, and their severity
Her low energy levels gave her no desire to eat and when she did, it triggered vomiting
Rockefeller Cancer Institute, the Arkansas Tobacco Settlement Commission, the National Center for Advancing Translational Sciences Grant No
References Healthline
Most people experience some weight regain after stopping GLP-1 medications, as hunger hormones return to pre-treatment levels
The search strategy combined the Medical Subject Heading (MeSH) terms exenatide OR liraglutide OR semaglutide OR dulaglutide OR albiglutide OR lixizenatide AND diabetes mellitus, type 2 AND a filter to identify RCTs 14
